Nausicaa Ventures

Nausicaa Ventures is a Brussels-based early-stage venture fund that backs high-tech hardware companies, with healthcare exposure concentrated in biotech and medical devices. The firm operates at the intersection of deep technology and life sciences, supporting Belgian and broader European founders building physical or biological products that require specialized engineering. There is no public artificial intelligence thesis attached to the fund. Limited public information is available about named investment partners or specific portfolio companies in the healthcare sub-verticals listed, beyond the firm’s general positioning as a hardware and life science investor.

Nausicaa Ventures focuses on Seed and Series A rounds with check sizes typically in the two hundred fifty thousand to one million dollar range. Geographic concentration is Belgium, with selective participation in adjacent European deals where Belgian co-investors or research institutions are involved. The fund participates rather than always leading rounds, and its small check size profile makes it most relevant for first institutional capital or as part of a syndicate alongside other regional and university-affiliated investors. Pacing aligns with the rhythm of European hardware and biotech early-stage activity rather than high-volume software venture.

For founders, Nausicaa is most useful when building hardware-intensive medical device or biotech businesses spinning out of Belgian universities, hospitals, or research centers, or when seeking a regionally credible early backer for a product with significant capital intensity. Expect diligence focused on technical risk, regulatory pathway, intellectual property, and capital plan to clinical or commercial milestones. Founders should be prepared to bring co-investors to fill out a round given the relatively small check size, and to communicate clearly how Belgian or European market entry factors into a broader commercialization strategy.